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infections (Xu, Chao, & Wan, 2009) . Additionally, the consumption of functional 70 oligosaccharides can reduce the risk of lifestyle-related diseases, such as cardiovascular 71 M A N U S C R I P T
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often exceeds the total amount of protein in mature human milk (Table 3) . Complex 104 oligosaccharides, particularly unconjugated complex glycans, HMOs, make up a high 105 percentage of the total solids in human milk. Nearly 200 HMOs have been identified, among 106 which more than 80 have been fully characterized from a structural perspective. The 107 biological functions of HMOs are closely associated with their structural conformation 108 (Bode, 2015) . Galactose, glucose, fucose, N-acetylglucosamine, and the sialic acid 109 derivative, N-acetyl-neuraminic acid are the five monosaccharide building blocks that can 110 constitute HMOs (Kobata, 2010) . These glycans can be fucosylated and/or sialylated (Fig.  111 2). All HMOs carry lactose (Galβ1-4Glc) at the reducing end, which can be elongated in a 112 β-1,3 or β-1,6-linkage by two different disaccharides, either type 1 carbohydrate structures 113 (containing Galβ1-3GlcNAc units) or type 2 structures (containing Galβ1-4GlcNAc units). 114
HMOs with more than 15 disaccharide units can form complex structural backbones and be 115 further modified by adding fructose and/or sialic acid. Studies have demonstrated that HMOs 116 can induce increased levels of bifidobacteria in the colonic flora of breast-fed infants, 117
accompanied by a great reduction in pathogenic potential bacteria, by the bifidogenic 118 activity of HMOs (Jin, Joo, Li, Choi, & Han, 2016) . HMOs were shown to greatly affect the 119 composition of the gut microflora. The HMOs lacto-N-fucopentaose I could be selectively 120 utilized by Bifidobacterium longum subsp. infantis, but not B. animalis subsp. lactis, making 121 it a promising potential prebiotic (Zhao et al., 2016) . HMOs protect from viral, bacterial, or 122 protozoan pathogens and affect fungal-host interactions (Hong, Ninonuevo, Lee, Lebrilla, 123 & Bode, 2009; Shoaf-Sweeney & Hutkins, 2009) . 124 125
Structural analysis of glycan oligosaccharides 126
Because of the complexity and heterogeneity of oligosaccharides, characterization 127 technologies for oligosaccharides are not as advanced as the technologies for characterizing 128 nucleic acids and proteins. Moreover, oligosaccharides are particularly difficult to separate, 129
analyze and obtain detail structural information due to the coexisting isomeric structures and 130 multiple connectivity sites. Many techniques have been developed to elucidate 131 oligosaccharide structural characterization in order to understand their specific functions, 132 however there is no legal method for analyzing and quantifying oligosaccharides (Table 4) . 133
The sensitive method of high-resolution mass spectrometry (HR-MS), which can provide a 134 good breadth of information, has become a main tool for oligosaccharide analysis (Bao, 
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matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 138 (MALDI-TOF/MS) and electrospray ionization ion trap mass spectrometry (ESI-ITMS) 139 indicated that complex oligosaccharides have a larger mass range compared to previous 140 techniques (Hsu, Chang, & Franz, 2006) . Although MALDI-MS has been used successfully 141 to characterize underivatised oligosaccharides, MALDI-TOF/MS and MALDI post-source 142 decay TOF/MS analysis are ten-fold more sensitive than MALDI-MS (Park, Yang, Kim, & 143 Kim, 2012) . Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) 144 can be used to analyze oligosaccharides directly or with analytical derivatization (Wang, 145 Chu, Zhao, He, & Guo, 2011) . A combination of negative-ion electrospray tandem mass 146 spectrometry (ES-MS/MS), methylation analysis, and 1 H nuclear magnetic resonance 147 spectroscopy ( 1 H-NMR) has been applied to identify new oligosaccharides. 13 C-and 148 1 H-NMR, together with ES-MS, have been applied to determine the structures of complex 149 sulfated oligosaccharides isolated from human milk (Balogh, Szarka, & Béni, 2015) . 150
FT-ICR has been used to detect oligosaccharides recently (Lee, An, Lerno, German, & 151 Lebrilla, 2011) . Additionally, the efficient method of nano-electrospray ionization mass 152 spectroscopy (nESI-MS) with quadruple ion trap has been used to identify the position of 153 fucose, types of linkages, and differentiation of linear and branched structures of isomeric 154 oligosaccharides from a complex mixture of native underivatised neutral oligosaccharides 155 (Pfenninger, Karas, Finke, & Stahl, 2002) . Detect interactions of proteins with glycans or 156 glycoconjugates by nESI-MS. The development of additional techniques may result in 157 structural characterization of isolated oligosaccharides. The structures of HMOs are quite 158 complex and novel techniques such as porous graphitic carbon (PGC) LC-MS are now 159 available to perform the separation and identification of most isomers (Ruhaak, Lebrilla, 160 Weimer, & Slupsky, 2013) . Oligosaccharides studies will benefit from the application of the 161 most advanced analytical methods, such as high performance anion exchange 162 chromatography (HPAEC) with pulsed amperometric detection (PAD) or capillary 163 electrophoresis (CE), which can be used to measure samples at picomole and femtomole 164 levels, respectively (Monti, Cattaneo, Orlandi, & Curadi, 2015; Morales, Corzo, & Sanz, 165 2008) . solvents that are often toxic; and carrying out the reactions under harsh conditions. The 178 laborious chemical synthetic pathway frequently results in low yields. The chemo-enzymatic 179 method involves glycosyltransferases (GT) and glycosidases (GH), which are the enzymes 180 naturally involved in oligosaccharide synthesis in prokaryotes and eukaryotes (Yu & Chen, 181 2016) . By exploiting these enzymes in the laboratory for the synthesis of oligosaccharides, 182 many of the challenges faced when using chemical synthesis could be overcome. Some 183 diferent complex oligosaccharides and derivatives with 3-11 monosaccharides units have 184 been reported by preparative-scale and improved large-scale productions (Table 5) . 185
Chemo-enzymatic methods can be applied in the synthesis of virtually any complex 186 oligosaccharide (Hanson, Best, Bryan, & Wong, 2004) . Enzymatic coupling has some 187 advantages over its chemical counterpart. The use of enzymes in the synthesis of 188 oligosaccharides has attracted growing interest as an alternative to chemical synthesis 189 (Koeller & Wong, 2001 ). Glycosyltransferase-catalyzed enzymatic and chemo-enzymatic 190 syntheses are widely considered to be effective ways for oligosaccharides production ( antimutagenicity, cancer metastasis inhibition, blood-clotting cascade and many other 220 pharmacological activities. However, the synergistic effect of a mixture of more structurally 221
oligosaccharides from the nature sources should also be investigated as, most likely, one 222 single will not provide the desired function. More efforts need to be applied for the 223 production of more complex oligosaccharides, especially the ones that are branched. The 224 large-scale production of oligosaccharides using multiple OPME systems or engineered E. 
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Arabinoxylo-oligosaccharides Xylose, arabinose 5-10 α-1,2, α-1,3, β-1,4
Clycosylsucrose Glucose, fructose 3 α-1,2, β-1,4
Fructo-oligosaccharides Sucrose, fructose 2-5 β-1,2
Galacto-oligosaccharides Galactose 2-5 β-1,2, α-1,4
Galacturono-oligosaccharides Galactosamine 2-9 α-1,4
Gentio-oligosaccharides Glucose 2-10 β-1,6
Glucose-oligosaccharides Glucose 2-10 α-1,2, β-1,3, β-1,6
Human milk oligosaccharides Glucose, galactose, GlcNAc 2-8 α-1,2, α-1,3, α-1,4, α-2,3, β-2,6, β-1,3, β-1,4
Isomalto-oligosaccharides Glucose 2-5 α-1,4
Lactosucrose Galactose, fructose 2-3 β-1,4
Lactulose Galactose, fructose 2 β-1,4
Malto-oligosaccharides Mannitose, glucose 2-10 α-1,2, α-1,4
Palatinose Glucose, fructose 2 β-1,6
Raffinose Galactose, fructose, glucose 3 β-1,2, α-1,4
Rhamnogalacturon-oligosaccharides Rhamnose, galactose 4-8 α-1,2, α-1,4, β-1,4
Soybean oligosaccharides Fructose, galactose, glucose 2-4 α-1,6
Stachyose Galactose, fructose, glucose 4 α-1,4
Xylo-oligosaccharides Xylose 2-7 α-1,4 M A N U S C R I P T Table 4 The main properties and applications with different methods for oligosaccharide analysis. 2. Developments in techniques for analysis of the oligosaccharide.
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3. Advances in the oligosaccharides synthesis.
